The Role of Antibodies in Transplantation

Overview

Journal Transplant Rev (Orlando)

Specialty General Surgery

Date 2009 Jul 25

PMID 19628382

Citations 6

Authors

Alexander T Chang

Jeffrey L Platt

Affiliations

Soon will be listed here.

Abstract

For the past 40 years, T cells have been considered the primary threat to the survival of allografts. However, antibodies can induce severe vascular disease of organ transplants, and this disease, particularly "antibody-mediated" rejection, has become a major clinical challenge. Not only do antibodies cause rejection, the rejection caused by antibodies resists treatment by conventional drug regimens. On the other hand, antibodies can induce a condition in which grafts seemingly resist antibody-mediated injury, which is accommodation. In this communication, we discuss the role of antibodies in the diagnosis and pathogenesis of rejection and accommodation, and suggest what we considered the major gaps in knowledge and directions research into this subject might productively take.

Citing Articles

Recent Advances across the Spectrum of Heart Failure and Heart Transplant.

Masarone D, Lombardi C, Falco L, Coscioni E, Metra M J Clin Med. 2024; 13(5).

PMID: 38592320 PMC: 10932249. DOI: 10.3390/jcm13051427.

Characteristics of Immunoglobulin M Type Antibodies of Different Origins from the Immunologic and Clinical Viewpoints and Their Application in Controlling Antibody-Mediated Allograft Rejection.

Matsuda Y, Hiramitsu T, Li X, Watanabe T Pathogens. 2020; 10(1).

PMID: 33374617 PMC: 7822424. DOI: 10.3390/pathogens10010004.

B cells with regulatory properties in transplantation tolerance.

Durand J, Chiffoleau E World J Transplant. 2016; 5(4):196-208.

PMID: 26722647 PMC: 4689930. DOI: 10.5500/wjt.v5.i4.196.

Oral manifestations in transplant patients.

Nappalli D, Lingappa A Dent Res J (Isfahan). 2015; 12(3):199-208.

PMID: 26005458 PMC: 4432601.

ABO-compatible liver allograft antibody-mediated rejection: an update.

Demetris A, Zeevi A, OLeary J Curr Opin Organ Transplant. 2015; 20(3):314-24.

PMID: 25944231 PMC: 4646419. DOI: 10.1097/MOT.0000000000000194.

References

Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin C, Funa K . Induction of transforming growth factor-beta during cardiac allograft rejection. J Immunol. 1993; 151(2):1147-57. View

Marcum J, Rosenberg R . Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemost. 1987; 13(4):464-74. DOI: 10.1055/s-2007-1003523. View

Mauiyyedi S, Colvin R . Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens. 2002; 11(6):609-18. DOI: 10.1097/00041552-200211000-00007. View

Pruitt S, Kirk A, Bollinger R, Marsh Jr H, Collins B, Levin J . The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation. 1994; 57(3):363-70. DOI: 10.1097/00007890-199402150-00009. View

Feucht H, FELBER E, Gokel M, Hillebrand G, Nattermann U, Brockmeyer C . Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol. 1991; 86(3):464-70. PMC: 1554190. DOI: 10.1111/j.1365-2249.1991.tb02954.x. View

Lee P, Terasaki P, Takemoto S, Lee P, Hung C, Chen Y . All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation. 2002; 74(8):1192-4. DOI: 10.1097/00007890-200210270-00025. View

Saadi S, Platt J . Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med. 1995; 181(1):21-31. PMC: 2191825. DOI: 10.1084/jem.181.1.21. View

Platt J, Nath K . Heme oxygenase: protective gene or Trojan horse. Nat Med. 1998; 4(12):1364-5. DOI: 10.1038/3947. View

Koch C, Khalpey Z, Platt J . Accommodation: preventing injury in transplantation and disease. J Immunol. 2004; 172(9):5143-8. DOI: 10.4049/jimmunol.172.9.5143. View

10.

Piazza A, Poggi E, Borrelli L, Servetti S, Monaco P, Buonomo O . Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation. 2001; 71(8):1106-12. DOI: 10.1097/00007890-200104270-00017. View

11.

Bach F, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T . Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med. 1997; 3(2):196-204. DOI: 10.1038/nm0297-196. View

12.

Starzl T, Ishikawa M, Putnam C, Porter K, Picache R, Husberg B . Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc. 1974; 6(4 Suppl 1):129-39. PMC: 3004363. View

13.

Delikouras A, Fairbanks L, Simmonds A, Lechler R, Dorling A . Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors. Eur J Immunol. 2003; 33(11):3127-35. DOI: 10.1002/eji.200323566. View

14.

Ihrcke N, Wrenshall L, Lindman B, Platt J . Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today. 1993; 14(10):500-5. DOI: 10.1016/0167-5699(93)90265-M. View

15.

Spector D, Limas C, Frost J, ZACHARY J, Sterioff S, Williams G . Perfusion nephropathy in human transplants. N Engl J Med. 1976; 295(22):1217-21. DOI: 10.1056/NEJM197611252952203. View

16.

Cerra F, Raza S, Andres G, Siegel J . The endothelial damage of pulsatile renal preservation and its relationship to perfusion pressure and colloid osmotic pressure. Surgery. 1977; 81(5):534-41. View

17.

KISSMEYER-NIELSEN F, Olsen S, PETERSEN V, FJELDBORG O . Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966; 2(7465):662-5. DOI: 10.1016/s0140-6736(66)92829-7. View

18.

Tzou P, De Gregorio E, Lemaitre B . How Drosophila combats microbial infection: a model to study innate immunity and host-pathogen interactions. Curr Opin Microbiol. 2002; 5(1):102-10. DOI: 10.1016/s1369-5274(02)00294-1. View

19.

Medawar P . Tests by tissue culture methods on the nature of immunity to transplanted skin. Q J Microsc Sci. 1948; 89(Pt 3):239-52. View

20.

Medawar P . Immunity to homologous grafted skin; the relationship between the antigens of blood and skin. Br J Exp Pathol. 2010; 27:15-24. PMC: 2065734. View